Expression and mutagenesis of recombinant human and murine erythropoietins in Escherichia coli

Expression of the polypeptide hormone erythropoietin (EPO) in Escherichia coli by four bacterial expression vectors was examined. Complementary DNAs encoding human and murine EPO were amplified by polymerase chain reaction (PCR) and cloned into the glutathione- S-transferase (GST) fusion vector, pGE...

Full description

Saved in:

Bibliographic Details
Published in:	Biochimica et biophysica acta Vol. 1261; no. 1; pp. 35 - 43
Main Authors:	Bill, Roslyn M., Winter, Paul C., McHale, Cliona M., Hodges, Vivien M., Elder, G.Elizabeth, Caley, Jane, Flitsch, Sabine L., Bicknell, Roy, Lappin, Terence R.J.
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 14-03-1995
Subjects:	Anemia - drug therapy Animals Base Sequence Chromatography, Affinity DNA, Complementary - genetics Erythropoiesis - drug effects Erythropoietin Erythropoietin - biosynthesis Erythropoietin - genetics Erythropoietin - isolation & purification Erythropoietin - pharmacology Escherichia coli - genetics Escherichia coli - metabolism Expression vector Gene Expression Regulation, Bacterial - drug effects Genes, Reporter Glutathione - metabolism Glutathione Transferase - biosynthesis Glutathione Transferase - genetics Humans Male Mice Mice, Inbred C57BL Molecular Sequence Data Mutagenesis, Site-Directed Mutant pGEX Polymerase Chain Reaction Recombinant Fusion Proteins - biosynthesis Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - isolation & purification Recombinant Fusion Proteins - pharmacology Solubility Species Specificity Spleen - drug effects Structure-Activity Relationship Thrombin - pharmacology pGEX Erythropoietin Mutant Expression vector
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Expression of the polypeptide hormone erythropoietin (EPO) in Escherichia coli by four bacterial expression vectors was examined. Complementary DNAs encoding human and murine EPO were amplified by polymerase chain reaction (PCR) and cloned into the glutathione- S-transferase (GST) fusion vector, pGEX-2T. Human EPO DNA was also cloned into the vectors, pET14b, pIN III-Omp A2 and pT7/7. Expression of human and murine EPO was obtained using constructs based on pGEX-2T. For constructs based on the other vectors, expression of EPO was absent or occurred at low levels, despite attempts to optimise conditions. Human and murine EPO, expressed as fusion proteins with GST, were partially soluble and displayed EPO bioactivity. Soluble GST-EPO fusion proteins were affinity purified on immobilised glutathione. Insoluble protein could also be purified by elution from gel slices following SDS-PAGE to yield either fusion protein or, after treatment with thrombin, unmodified EPO which was both soluble and bioactive. The pGEX expression system was evaluated as a means of analysing the structure-function relationships of EPO by in vitro mutagenesis. Three human and three murine EPO mutants were constructed and expressed as GST fusion proteins. Following purification, biological activity was evaluated using assays for bioactivity, immunoactivity and GST activity. The pGEX expression system complements eukaryotic systems described previously for expression of EPO and should provide much useful information about the structure-function relationships of the hormone.
ISSN:	0167-4781 0006-3002 1879-2634
DOI:	10.1016/0167-4781(94)00213-M